FDA grants Priority Review to Promacta sNDA

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) said FDA granted Priority Review to an sNDA from partner GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) for Promacta eltrombopag to treat thrombocytopenia in adults ...